Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial. [electronic resource]
Producer: 20130612Description: 45-54 p. digitalISSN:- 1533-712X
- Adolescent
- Adrenergic Uptake Inhibitors -- adverse effects
- Adult
- Analysis of Variance
- Atomoxetine Hydrochloride
- Attention -- drug effects
- Attention Deficit Disorder with Hyperactivity -- diagnosis
- Double-Blind Method
- Executive Function -- drug effects
- Humans
- Least-Squares Analysis
- Predictive Value of Tests
- Propylamines -- adverse effects
- Prospective Studies
- Psychiatric Status Rating Scales
- Puerto Rico
- Quality of Life
- Recovery of Function
- Severity of Illness Index
- Time Factors
- Treatment Outcome
- United States
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.